• Aberystwyth University Featured Masters Courses
  • University of Derby Online Learning Featured Masters Courses
  • University of Surrey Featured Masters Courses
  • Birmingham City University Featured Masters Courses
  • Xi’an Jiaotong-Liverpool University Featured Masters Courses
  • Northumbria University Featured Masters Courses
  • University of Bristol Featured Masters Courses
Cranfield University Featured Masters Courses
Queen Margaret University, Edinburgh Featured Masters Courses
Staffordshire University Featured Masters Courses
University College Cork Featured Masters Courses
Swansea University Featured Masters Courses
"clinical" AND "drug" AND…×
0 miles

Masters Degrees (Clinical Drug Development)

We have 177 Masters Degrees (Clinical Drug Development)

  • "clinical" AND "drug" AND "development" ×
  • clear all
Showing 1 to 15 of 177
Order by 
Programme description. Over the last 30 years healthcare research and drug development have been transformed from peripheral activities carried out on an ad hoc basis to become core activities that require trained, professional, staff. Read more
Programme description
Over the last 30 years healthcare research and drug development have been transformed from peripheral activities carried out on an ad hoc basis to become core activities that require trained, professional, staff.

We have developed a modular postgraduate programme in clinical drug development designed to give you the necessary academic background and specialist skills needed to carry out clinical drug development in a contract research organisation , pharmaceutical industry or health service environment.

If you are a nurse, medical doctors or other health professionals working in contract research organisations, the pharmaceutical industry and healthcare, this programme has been designed for you.

Programme outline
This postgraduate programmes shares a common spine with our Healthcare Research Methods programme, which covers the key areas of expertise needed for a successful clinical research programme.If you choose the Clinical Drug Development programme, your initial modules will concentrate on early drug development.

The modular nature of the programmes is designed to fit in with full-time employment. The taught elements of the modules are delivered in three-day blocks every six weeks.

Core modules:

Clinical Study Design
Practical Aspects of Clinical Research and Early Drug Development
Ethics and Regulation
Data Management and Statistics
Specific Topics in Clinical Trial Design
Elective Dissertation
Health Outcomes and Pharmacoeconomics
Marketing Healthcare
Research Project / Dissertation
Drug Discovery and Pre-clinical Research and Development
Toxicology
Module options include:

Health and the Human Body
Healthcare Organisation and Decision Making

Read less
The aim of the Distance Learning (DL) PGDip/MSc in Clinical Drug Development course is to provide students with a multi-disciplinary perspective to facilitate their skills. Read more
The aim of the Distance Learning (DL) PGDip/MSc in Clinical Drug Development course is to provide students with a multi-disciplinary perspective to facilitate their skills. This course is designed for individuals who need an understanding of the drug development process, and provides a detailed picture of the complex and highly interrelated activities required for the development cycle for drugs and biologics, from the process of discovery to successful commercialisation. The DL PGDip/MSc in Clinical Drug Development provides students the edge that pharmaceutical industry requires. It also empowers the professionals working within the field with the skills and understanding required for fast progression within the industry and contract research organisations (CRO-s).
The modular nature of the courses is designed to fit in with the needs of those students who are in full time employment. The taught element of the modules is delivered in three-day blocks every four to six weeks (approximately). For a PGDip award students have to complete in total of 7 modules, while for an MSc award students need to complete 10 modules in total.
Module Titles:
Drug Discovery & Pre-Clinical Research & Development
Toxicology: From Molecules to Man
Clinical Study Design
Practical Aspects of Clinical Research & Early Drug Development
Ethics & Regulation in Clinical Research
Data Management: The Interpretation of Statistics & Pharmacokinetics
Specific Topics in Clinical Trial Design and Elective Project
Health and Pharmaco-Economics
Pharmaceutical & Healthcare Marketing
Dissertation
The final mark will have the following components
• Continuous assessment (module assignment)
• Dissertation

Read less
This MSc offers specialised training in biomedical science with exposure to leading research scientists, biotechnologists and the pharmaceutical industry. Read more

This MSc offers specialised training in biomedical science with exposure to leading research scientists, biotechnologists and the pharmaceutical industry. It provides a foundation for a career in drug development and a comprehensive programme in research methodology, the translation of basic research into therapies and the governance and social implications of health research.

About this degree

Students develop practical understanding of research methods in biomedical science and knowledge of cutting-edge research alongside practical experience in laboratory, clinical or epidemiological research. They develop the ability to evaluate scientific literature and gain an appreciation of ethical and governance requirements of research, including 'Good Clinical Practice' principles. Graduates of this MSc go on to have successful careers in both academia and in industry.

Students undertake modules to the value of 180 credits.

The programme consists of six core modules (120 credits) and a research dissertation (60 credits).

A Postgraduate Diploma consisting of six core modules (120 credits) is offered.

A Postgraduate Certificate consisting of two core modules (60 credits) is offered.

Core modules

  • Drug Discovery I
  • Drug Discovery II
  • Statistical Methods in Research
  • Ethics and Regulation of Research
  • Clinical Pharmacology and Therapeutics
  • Advanced Pharmacology and Therapeutics

Optional modules

There are no optional modules for this degree.

Research project/report

All MSc students undertake an independent research project which culminates in a report of 10,000 words.

Teaching and learning

The programme is delivered through a combination of lectures, practicals, small-group seminars and laboratory work. Assessment is through presentations, essays, examination and the research project and dissertation.

Further information on modules and degree structure is available on the department website: Clinical Drug Development MSc

Careers

The programme provides an ideal foundation for graduates who wish subsequently to undertake a PhD in biomedical science, and provides key transferable skills for those wishing to pursue careers in drug development.

Recent career destinations for this degree

  • Clinical Trial Practitioner, Barts Cancer Institute
  • Clinical Research Assistant, Alberta Children's Hospital

Employability

This programme runs within the School of Life and Medical Sciences, one of the most highly rated medical research organisations in the UK. Close links with clinical colleagues in the UCLH group of hospitals provides cutting-edge medical expertise and links to world-leading clinical research. Graduates of the programme have pursued careers in the pharmaceutical industry and medicine, and a significant proportion go on to study for PhD degrees at UCL and other institutions worldwide.

Careers data is taken from the ‘Destinations of Leavers from Higher Education’ survey undertaken by HESA looking at the destinations of UK and EU students in the 2013–2015 graduating cohorts six months after graduation.

Why study this degree at UCL?

The Division of Medicine has as its mission the performance of innovative, high-quality biomedical research and excellence in graduate teaching.

This MSc programme provides an opportunity for students to develop theoretical knowledge, understanding and practical skills in research methodology. These include statistical methods applied to medical research, drug development in a specific biomedical area or health specialty, and the ethics and governance of applied health research.

Over the course of the year, students will have the opportunity to build a network of contacts from both academia and industry, improving their future career prospects.

Research Excellence Framework (REF)

The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.

The following REF score was awarded to the department: Division of Medicine

80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)

Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.



Read less
This MRes offers specialised training with exposure to research scientists and members of the pharmaceutical industry. It provides a foundation year for a research career in drug development and a comprehensive programme in research methodology. Read more

This MRes offers specialised training with exposure to research scientists and members of the pharmaceutical industry. It provides a foundation year for a research career in drug development and a comprehensive programme in research methodology. Students will undertake a significant research project during this MRes.

About this degree

Students develop practical understanding of research methods in biomedical science and knowledge of cutting-edge research techniques alongside practical experience in laboratory, clinical or epidemiological research. They develop the ability to evaluate scientific literature and gain an appreciation of ethical and governance requirements of research, including 'Good Clinical Practice' principles.

Students undertake modules to the value of 180 credits.

The programme consists of four core taught modules (75 credits) and a research dissertation (105 credits).

A Postgraduate Diploma (120 credits) is offered.

Core modules

  • Drug Discovery 1
  • Statistical Methods in Research
  • Clinical Pharmacology
  • Advanced Clinical Pharmacology or Ethics and Regulation Research

Optional modules

There are no optional modules for this programme.

Dissertation/research project

All MRes students undertake an independent research project which culminates in a dissertation of 15,000 words.

Teaching and learning

The programme is delivered through a combination of lectures, practicals, small group seminars and laboratory work. Assessment is through presentations, essays, examination and the research dissertation.

Further information on modules and degree structure is available on the department website: Clinical Drug Development MRes

Careers

Graduates of the programme have used the qualification to pursue careers in the pharmaceutical industry and medicine, while a significant proportion of students go on to study for PhD degrees at UCL and other institutions worldwide.

Recent career destinations for this degree

  • Post-Doctoral Researcher, King's College London

Employability

This programme runs within the School of Life and Medical Sciences, one of the most highly rated medical research organisations in the UK. Close links with clinical colleagues in the UCL group of hospitals provides cutting-edge medical expertise and links to world-leading clinical research.

Careers data is taken from the ‘Destinations of Leavers from Higher Education’ survey undertaken by HESA looking at the destinations of UK and EU students in the 2013–2015 graduating cohorts six months after graduation.

Why study this degree at UCL?

The Division of Medicine has as its mission the performance of innovative, high-quality biomedical research and excellence in graduate training.

This MRes programme provides an opportunity for students to develop theoretical knowledge, understanding and practical skills in research methodology. These include statistical methods applied to medical research and drug development in a specific biomedical area.

Over the course of the year, students will have the opportunity to build a network of contacts from both academia and industry, increasing their future career prospects.

Research Excellence Framework (REF)

The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.

The following REF score was awarded to the department: Division of Medicine

80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)

Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.



Read less
The studies in Drug Discovery and Development give you a deep understanding of up-to-date methods applied to identify and validate new drug targets and to generate lead drug molecules. Read more

The studies in Drug Discovery and Development give you a deep understanding of up-to-date methods applied to identify and validate new drug targets and to generate lead drug molecules. It also provides knowledge of technological innovations as well as methods of clinical drug research and development phases, clinical trial design, study planning and biostatistics. In addition, you will learn about drug regulatory science and pharmacovigilance.

After graduation, you will master drug discovery and development processes as well as procedures applied in drug regulatory science. You will also be familiar with the role of drug regulatory authorities during the life-span of a drug. The University of Turku also offers Drug Research Doctoral Programme for post-graduate studies.

You will get comprehensive skills to work in the field of biomedicine and drug discovery in companies, universities, research institutes or drug regulatory authorities. The Programme also gives a good foundation for those interested in entrepreneurship.

Academic excellence and experience

Turku is a great place to study drug discovery and development! Of the Finnish drug innovations, 90 per cent have been made in Turku. To support the future discoveries, the University of Turku has chosen drug development as one of its strategic profiling areas.

The research in biosciences and medicine is internationally ranked among the top in the world. The keys for success lie in long biomedical research traditions and a compact campus area where two universities and a university hospital operate to create an interdisciplinary and innovative study and research environment.

Research focus is on translational medicine, disease modelling and biomedical imaging. Available infrastructure includes the world famous Turku PET Centre and Turku Centre for Disease Modeling, both of which offer services for drug development research.

Turku also has the largest cluster of pharma industry in Finland. Nearby companies not only provide experts for visiting lectures, but also create internship and job opportunities for the graduates.

Master's thesis and topics

The Master’s thesis project is based on independent, experimental research work.

You must always agree on your thesis topic with your thesis examiner who also accepts the topic. You will write a research plan, conduct a research project in a laboratory, analyse obtained results, and demonstrate your ability to interpret results and write a report in a form of a scientific article. The project work is always performed under the guidance of a supervisor.

In order to also practice scientific communication, you will present your results in a seminar and write a press release to stimulate collaboration between the academia and the media.

Examples of thesis topics:

  • Drug development for receptor antagonists and their potential in treating cognitive disorders
  • Pharmacological characterization of ion channels
  • Diagnostics tools for coronary artery diseases – characterization of antibodies
  • Modelling of schizophrenic disorders in rats
  • RNA interference in HSV-virus treatment
  • Optimization of synthesis of indatsole structures for drug development
  • The use of positron emission tomography (PET) to measure the effect of disease modifying therapies in MS disease
  • PET-imaging of molecules targeted in inflammation – preclinical studies with arthritis model

Competence description

The studies in Drug Discovery and Development provide you with a deep understanding of:

  • up-to-date methods applied to identify and validate new drug targets, and to generate lead drug molecules that modulate biological activity of the target
  • technological innovations made in lead optimisation process
  • how new drug candidates are investigated during the non-clinical drug development phase
  • methods of clinical drug research, clinical drug development phases, clinical trial design and biostatistical study planning
  • various aspects of the drug regulatory science and pharmacovigilance

Job options

After graduation, you will be an expert in drug discovery and development processes. You will know the procedures applied in drug regulatory science and the role of drug regulatory authorities during the life-span of a drug.

You will learn comprehensive skills to work in the field of biomedicine and drug discovery in companies, universities, research institutes or drug regulatory authorities. The Programme also gives a good foundation for those interested in entrepreneurship.

  • Possible job titles are:
  • medical liaison
  • medical writer
  • regulatory consulting expert
  • scientific/technical advisor
  • research director
  • project manager
  • drug development pharmacologist
  • university lecturer/researcher

Career in research

The Master of Science degree completed in the Programme qualifies the graduates for PhD studies in Turku, elsewhere in Finland or universities worldwide. Graduates from the Programme are eligible to apply for a position in the University of Turku Graduate School, UTUGS. The Graduate School consists of 16 doctoral programmes which cover all disciplines and doctoral candidates of the University.

Together with the doctoral programmes, the Graduate School provides systematic and high quality doctoral training. UTUGS aims to train highly qualified experts with the skills required for both professional career in research and other positions of expertise.

Several doctoral programmes at University of Turku are available for graduates:



Read less
Help improve human or animal health through creating new or more effective drugs and medicines. Learn the research processes used to identify drug targets and develop new therapeutics. Read more

Help improve human or animal health through creating new or more effective drugs and medicines. Learn the research processes used to identify drug targets and develop new therapeutics.

Your studies will combine the biological sciences with chemistry, giving you the skills to target, design, synthesise, create and assess new drugs. You'll also learn about protecting intellectual property, assessing the financial viability of drugs and the pre-clinical and clinical trial processes.

Tailor your studies to your strengths, interests and career goals. You'll learn a mix of academic and practical skills that are closely aligned to the needs of industry.

The Master of Drug Discovery and Development is best suited to very able students with backgrounds in chemistry or relevant life-science subjects such as biochemistry, biomedical science, pharmacy or pharmacology. It is an intensive one-year taught programme, unique in New Zealand.

Learn from the best

Learn from academics and professionals who are leaders in the field and have experience in successfully taking drugs to market. Each course is taught by at least three academics so you'll be exposed to a wide range of expertise.

Drug Discovery and Development is taught by the Schools of Chemical and Physical Sciences and Biological Sciences in collaboration with the University's Ferrier Research Institute and the Centre for Biodiscovery.

You'll be able to take advantage of the research expertise of the Ferrier Research Institute in drug design and development, and if you're doing a Master's, you'll be working alongside the more than 30 scientists who make up the largest carbohydrate research team in the world. The Institute also has its own manufacturing facility so you'll have the opportunity to observe the drug development process from discovery to product.

You'll also benefit from the programme's links with the Centre for Biodiscovery where you will interact with the research teams that are actively discovering, designing and assessing novel bioactive compounds.

Drugs in the real world

Get wise to the real-world issues facing pharmaceutical development and make the most of the hard-earned experiences of staff who have worked in the local and international biotech industry. Learn not only how to handle chemicals on a large scale, but to develop the mindset to do this in a way that is safe, reliable and robust—so you end up providing medicines that will change people’s lives.

Victoria offers three postgraduate qualifications in Drug Discovery and Development. Choose the one that suits your career goals, time constraints and financial situation.

  • Master of Drug Discovery and Development
  • Postgraduate Diploma in Drug Discovery and Development
  • Postgraduate Certificate in Drug Discovery and Development

If you begin by enrolling in the Certificate or Diploma programme you can continue on to complete your Master's. Or if you enrol in the Master's but can't complete it, for whatever reason, you may have completed enough points to be awarded a Certificate or Diploma.

What you'll study

Each qualification includes the core courses DRGD 401 Chemical Biology and Drug Discovery, and a choice between DRDG 402 Drug Design or CHEM 421 Organic Chemistry and Bio-organic Chemistry.

After that you'll choose from selected courses from the study areas of Drug Discovery and Development, Biomedical Science, Biotechnology, Chemistry, Clinical Research and Microbiology.

All three qualifications give you the opportunity to do at least some research.

Postgraduate Certificate

You'll complete four courses worth 60 points made up of the two core courses and two further choices.

Postgraduate Diploma

You're likely to take seven courses that will include the two core courses, your elective options and the 30-point Research Preparation course.

Master's

You'll study for your Master's in two parts over three trimesters. In Part 1, the first two trimesters, you're likely to take seven courses that will include the core courses and a 30-point Research Preparation course.

In Part 2, you'll complete a full research project. Choose between DRDG 561 Applied Research Project, where you'll complete one or more problem-solving projects, or DRGD 590 Research Project, where you'll focus on medicinal chemistry and the formulation of active pharmaceutical products. In some cases you may be able to replace the research project with the thesis course DRGD 595.

Your Master's may be endorsed with a specialisation in either Drug Discovery, Drug Development or Chemical Biology. Check the requirements to find out what you need to do for these.

Workload and duration

You can expect a workload of 40–45 hours a week for much of your studies.

The MDDD can be completed in 12 months full time, or in two years of part-time study but you'll need to discuss this option with the programme directorfirst. The Diploma will take you two trimesters and the Certificate one trimester.

Location

You'll study at Wellington's Kelburn campus where you will have access to state-of-the-art research facilities. Students doing a research programme will also work in partnership the world-renowned Ferrier Research Institute in Lower Hutt.

Research topics

Be part of a dynamic and collaborative scientific research community. Past students' research areas in drug discovery and development have included:

  • development of a new scaled-up catalytic process for a high value fine chemical
  • isolation and characterisation of a novel bioactive from a New Zealand marine organism
  • formulation of a novel therapeutic for cancer immunotherapy.

Community

Become part of an active community of scientists. Postgraduate study at Victoria will help you build valuable relationships and networks with peers, university staff and future colleagues. You'll have unprecedented access to world industry leaders who visit as guest lecturers and run seminars with students.

Careers

You'll have the broad skills you need to work in drug discovery in companies, universities, research institutes or with drug regulatory authorities. You might work within the pharmaceutical, bioanalytical or chemical industries, or take your skills into nutraceuticals or agrichemicals.



Read less
This course offers knowledge and expertise relevant to a senior role in clinical research in a pharmaceutical, biotechnology, device, contract research or site management company or the NHS. Read more

This course offers knowledge and expertise relevant to a senior role in clinical research in a pharmaceutical, biotechnology, device, contract research or site management company or the NHS.

Overview

If your line of work involves clinical research, this course is designed to help you advance and enhance your career.

Whether you work in the pharmaceutical industry, health service, for a contract research organisation, regulatory authority, data management organisation or in medical writing, we have tailored this programme to give you an outstanding grounding in clinical research skills and knowledge.

It’s the leading part-time, face-to-face MSc in Clinical Research and, by undertaking this course, you’ll be equipped to meet good clinical practice and regulatory quality standards for developing new healthcare interventions to improve treatments for patients.

The programme presents an overview of clinical trial processes and the regulations for bringing in a new chemical entity, and explores a broad range of therapeutic areas and their treatments in relation to clinical trials, drug registrations and drug safety.

We will support you to move confidently between these therapeutic areas and therefore increase your potential value to employers. In your dissertation year, you’ll be encouraged to carry out projects which have direct value to your employer, making this a highly attractive course for your employer to support.

This part-time MSc programme is recognised by the pharmaceutical industry and the Health Service as being of outstanding quality and practical value in the work place to clinical research professionals.

The programme is run over three calendar years of part-time study and is in a modular format. Teaching happens over four two-day sessions per year which takes place within Cardiff’s School of Pharmacy and Pharmaceutical Sciences. These session are always scheduled at weekends to accommodate students’ existing employment commitments.

Distinctive features

  • You will gain advanced understanding of best practice in clinical research to apply to running clinical trials.
  • You’ll experience in-depth training in drug development, clinical trials, and regulatory GCP requirement for clinical trials
  • Lecturers from Pharmaceutical Industry will provide you with an up-to-date overview on key developments in Clinical Research
  • Clinical Research trainers deliver a variety of teaching methods that enhance the course and will stimulate your learning.
  • The therapeutic modules will widen your skills in an array of medical settings.
  • The diversity of employment backgrounds of participants affords an ideal environment for networking with other clinical research personnel.
  • You’ll have the opportunity to undertake a research project at an internationally recognised research school at Cardiff University.
  • You’ll receive close academic support from an experienced personal tutor with an international background in compliance with clinical trial GCP and regulatory requirements.
  • You’ll develop critical analysis, personal reflection and enhanced clinical trial project communication and problem solving skills for career development in clinical research.

Career prospects

Clinical research is an expanding and highly competitive area. Undertaking this MSc will provide you with the skills and knowledge needed to advance and enhance a career in clinical research. 

This programme is suitable for graduates from healthcare, life sciences or other related disciplines, and healthcare professionals who are interested in a career in clinical trials in the health service, pharmaceutical, biotechnology, device industries, Contract Research Organisations/ suppliers to the pharmaceutical industry. It is also ideal for professionals working in clinical trials who wish to further develop their knowledge and skills of clinical trials.

Potential career opportunities include clinical trials, clinical research, clinical data management, regulation of clinical trials, medical writing, academic clinical trials, Phase I clinical trials units, the pharmaceutical industry, hospitals, archiving in clinical trials, quality assurance in clinical trials, clinical research project management, clinical trial administration, clinical trial co-ordinator, clinical trial administration/support to clinical trials and more.

After successfully completing this course, you will have an advanced standing both clinically and academically, with the potential to be at the forefront of your chosen profession.



Read less
The objective of the course is to equip students with a strong foundation in the fundamental techniques of clinical and translational research in experimental medicine, applying contemporary research tools to clinically relevant areas of investigation. Read more
The objective of the course is to equip students with a strong foundation in the fundamental techniques of clinical and translational research in experimental medicine, applying contemporary research tools to clinically relevant areas of investigation. The bespoke experimental medicine research training will be taught by Cambridge academics and industry, and will incorporate a research project focused experimental medicine. Each student is allocated an individual supervisor, who will provide support throughout the course and help build a customised training programme.

The MPhil includes formal modular teaching in core experimental modules (Statistics, Epidemiology, and Practical Aspects of Clinical Research) as well as specialist modules in Clinical Pharmacology and Clinical Drug Development. In addition, all students will have the opportunity to undertake a relevant 12 week research projects with one of our outstanding supervisors, including clinicians across a range of specialties, bio-medical scientists and bio-medical industry partners.

The course aims to provide students with broad research study and communications skills.

See the website http://www.graduate.study.cam.ac.uk/courses/directory/cvmdmptmt

Course detail

Upon successful completion of the MPhil graduates will have developed a strong foundation in the fundamental knowledge and techniques required to enable them to undertake clinical and translational research in experimental medicine. They will be able to apply contemporary research tools to clinically relevant areas of investigation.

The MPhil programme will produce clinical researchers who are competitive in seeking research support and
who are knowledgeable about the complex issues associated with conducting sound clinical research and
trials.

Format

The course consists of core modules in Practical Aspects of Clinical Research, Statistics, Epidemiology, as well as bespoke modules in Clinical Pharmacology and Clinical Drug Development timetabled over two terms. Students from both themes (Experimental Medicine and Rare Diseases) will have the opportunity to attend the modules of the other theme.

Students will be allocated mentor groups to work on a group research project; and all students will conduct their own individual supervised 12 week research project for which they will submit a thesis. The course is examined by two sat exams and thesis assessment.

Assessment

Students are expected to submit a thesis with a maximum word count of 15000 words.

Students will sit two exams of 2 hours each. The exams will be multiple choice questions and structured answer questions.

Students are required to present their work to their supervisors lab and a supervisor report is submitted to the programme directors - this is not assessed, but gives an indication of the progress of the student.

The course components are completed by the end of July. However, to complete the course, students will be required to attend a viva in person on a date (to be announced) in late August or early September.

Continuing

Students who are progressing well, have the support of a Principal supervisor, and have the necessary funding, may apply during the year to continue to do a PhD on successful completion of their MPhil. Such students will need to gain a pass mark of 70% or more in the MPhil examination.

Find out how to apply here http://www.graduate.study.cam.ac.uk/applying

Funding Opportunities

There are no specific funding opportunities advertised for this course. For information on more general funding opportunities, please follow the link below.

General Funding Opportunities: http://www.graduate.study.cam.ac.uk/finance/funding

Read less
Our MSc Model-based Drug Development course provides the knowledge and skills for making evidence-based decisions at various stages of drug development. Read more

Our MSc Model-based Drug Development course provides the knowledge and skills for making evidence-based decisions at various stages of drug development.

It covers the scientific and regulatory aspects of evaluating a drug, with emphasis on the use of modelling and simulation methods. You will learn why these methods are so highly valued by industry and regulatory authorities as effective, cost-saving, decision-making tools. Learning is reinforced via hands-on application of the skills to real data.

The course has been developed with an emphasis on mechanistic approaches to assessing and predicting pharmacokinetics and pharmacodynamics (PKPD), such as physiologically-based pharmacokinetics (PBPK) .

As this comes under the general umbrella of systems biology, you will be able to apply your knowledge of modelling and simulation in various areas of research within the pharmaceutical industry.

Full-time students benefit from immersion in the varied biomedical research environment at The University of Manchester, including interaction with research staff at the renowned Centre for Applied Pharmacokinetic Research .

Alternatively, part-time students already working in the pharmaceutical industry can take advantage of the flexible, distance learning mode of the course, which allows you to fit study around other commitments.

Aims

The aim of the course is to provide specialist knowledge and skills that are highly relevant for a career linked to drug development and pharmaceutical industry.

It is designed for science, engineering or mathematics graduates who want to acquire:

  • awareness of the commercial and regulatory factors in drug development;
  • understanding of the physiological, chemical, and mathematical foundations used to define the safe and effective use of potential medicines;
  • training in the use of mathematical modelling and simulation methods to guide drug development.

The course aims to:

  • provide background information on the theory and methods for quantitative assessment of drug absorption, distribution and elimination;
  • provide an understanding of the role of pharmacometrics in the process of drug development;
  • provide background information on in vitro assays used to characterise ADME properties of new drug entities;
  • indicate the mathematical framework that is capable of integrating in vitro information with knowledge of the human body to predict pharmacokinetics;
  • provide familiarity and experience of using different software platforms related to pharmacometric data analysis including R, Phoenix, NONMEM, MATLAB, Simcyp, WinBUGS and MONOLIX;
  • equip you to reflect upon influential research publications in the field, to critically assess recent published literature in a specific area;
  • provide awareness of the elements of a convincing research proposal based on modelling and simulation;
  • provide the opportunity to undertake a project and carry out original research.

Special features

Distance learning option

Our distance learning option is ideal for scientists linked to the pharmaceutical industry who wish to expand their expertise while working in the industry.

Full-time mode

The full-time mode allows suitably trained mathematics, science or engineering graduates to focus on obtaining the advanced skills needed for a career in this area. We utilise a blended learning approach in which online learning content is supported by regular face-to-face contact with tutors.

Hands-on learning

Your learning will be reinforced over the duration of the course via hands-on application of your skills to real data.

Additional course information

The course focuses on the following topics.

  • Pharmacokinetics: addressing how a drug dose is administered to the body and the fate of drug molecules that enter the body.
  • Pharmacodynamics: addressing the chemical and physiological response of the body to drug.
  • Pharmacometrics: the science that quantifies drug, disease and trial information to aid efficient drug development and/or regulatory decisions (definition used by the US FDA).
  • Systems pharmacology: analysis of interactions between drug and a biological system, using mathematical models.
  • In vitro: in vivo extrapolation using physiologically based pharmacokinetic models (IVIVE-PBPK).

Teaching and learning

The course emphasises the development of problem-solving skills. A large portion of the learning involves structured problems requiring you to apply theory and practical skills to solve typical problems that arise in drug development.

The following teaching and learning methods are used throughout the course:

  • taught lectures;
  • hands-on workshops;
  • self-directed learning to solve given problems;
  • webinars and tutorials by leading scientists in industry/academia;
  • supervised research;
  • mentorship in solving problems and writing the research dissertation;
  • independent study.

Coursework and assessment

We assess your achievement of the learning outcomes for this course through:

  • unit assignments (submitted electronically);
  • unit examinations;
  • research project dissertation and oral presentation.

Career opportunities

This course was originally developed for scientists working within the pharmaceutical industry who wished to qualify as modellers with hands-on experience. The qualification will enhance your abilities within your current role or provide you with skills to progress into new posts.

The course is also appropriate for science and engineering graduates who wish to enter the industry. The role of modelling and simulation or pharmacometrics is assuming greater and greater importance in the pharmaceutical industry.

Pharmaceutical companies and government regulatory agencies are recognising its value in making best use of laboratory and clinical data, guiding and expediting development and saving time and costs.

A range of well-paid jobs exist in this area across the globe. Scientific and industry publications often discuss the current shortage and growing need for modellers.



Read less
Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies. Read more

Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies.

You will learn how to master experimental cancer through a combination of traditional teaching and hands-on learning, spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units.

The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing.

Alongside the taught elements, you will be allocated to one or more clinical trials that are being conducted by The Christie experimental cancer medicine team. You will have a named trainer and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.

Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.

For clinical trials coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.

You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.

Aims

The primary purpose of the MRes in Experimental Cancer Medicine is to provide you with the opportunity to work within a premier UK Phase 1 cancer clinical trials unit and, through a mix of taught and experiential learning, master the discipline of Experimental Cancer Medicine.

Special features

Extensive practical experience

You will spend most of your time gaining hands-on experience within The Christie's Experimental Cancer Medicine Team.

Additional course information

Meet the course team

Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie. She completed a PhD at Cambridge, investigating translational therapeutics and biomarker assay design in pancreatic cancer.

Professor Hughes is Chair of Experimental Cancer Medicine at the University and Strategic Director of the Experimental Cancer Medicine team at The Christie. He is a member of the research strategy group for Manchester Cancer Research Centre. He serves on the Biomarker evaluation review panel for CRUK grant applications.

Professor Hughes was previously Global Vice-President for early clinical development at AstraZeneca, overseeing around 100 Phase 0/1/2 clinical studies. He was previously Global Vice-President for early phase clinical oncology, having been involved in over 200 early phase clinical studies.

Dr Matthew Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie.

He has a PhD in circulating biomarkers and postdoctoral experience in single cell and ctDNA molecular profiling. He is Principal Investigator on a portfolio of phase 1 clinical trials and has research interests in clinical development of novel drugs for lung cancer and integration of biomarkers with experimental drug development.

Teaching and learning

Our course is structured around a 2:1 split between clinical-based research projects and taught elements respectively.

Taught course units will predominantly use lectures and workshops.

For the research projects, teaching and learning will take place through one-to-one mentoring from a member of the Experimental Cancer Medicine team.

The clinical and academic experience of contributors to this course will provide you with an exceptional teaching and learning experience.

Coursework and assessment

You will be assessed through oral presentations, single best answer exams, written reports and dissertation.

For each research project, you will write a dissertation of 10,000 to 15,000 words. Examples of suitable practical projects include the following.

Research proposal

  • Compilation of a research proposal to research council/charity
  • Writing a protocol and trial costings for sponsor
  • Research and write a successful expression of interest selected by grant funder for full development

Publication-based/dissertation by publication

  • Writing a clinical study report
  • Authoring a peer-review journal review/original article

Service development/professional report/ report based dissertation

  • Public health report/outbreak report/health needs assessment/health impact assessment
  • Proposal for service development/organisational change
  • Audit/evaluate service delivery/policy
  • Implement recommended change from audit report

Adapted systematic review (qualitative data)

  • Compiling the platform of scientific evidence for a new drug indication from literature
  • Review of alternative research methodologies from literature

Full systematic review that includes data collection (quantitative data)

  • Referral patterns for Phase 1 patients

Qualitative or quantitative empirical research

  • Design, conduct, analyse and report an experiment

Qualitative secondary data analysis/analysis of existing quantitative data

  • Compilation, mining and analysis of existing clinical data sets

Quantitative secondary data analysis/analysis of existing qualitative data/theoretical study/narrative review

  • Policy analysis or discourse analysis/content analysis
  • A critical review of policy using framework analysis

Facilities

Teaching will take place within The Christie NHS Foundation Trust , Withington.

Disability support

Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: 

Career opportunities

This course is relevant to physician, nursing and clinical research students who are considering a career in Phase 1 clinical studies.

The course provides a theoretical and experiential learning experience and offers a foundation for roles within other experimental cancer medicine centres within the UK and EU, as well as careers in academia, the pharmaceutical industry, clinical trials management and medicine.

The MRes is ideal for high-calibre graduates and professionals wishing to undertake directly channelled research training in the clinical and medical oncology field.



Read less
The Clinical Pharmacology course will give you the advanced skills and knowledge to evaluate the safety of new medicinal products in preparation for medical approval. Read more

The Clinical Pharmacology course will give you the advanced skills and knowledge to evaluate the safety of new medicinal products in preparation for medical approval. It is one of three modular programmes in Pharmaceutical Medicine designed for working physicians, clinical scientists and allied health professionals interested in the clinical development process.

Key benefits

  • King's is ranked 7th in the world for Pharmacy & Pharmacology (QS World University Rankings by Subject 2017)
  • Lectures delivered by experienced multi-disciplinary researchers from the biopharmaceutical sector and the regulatory authorities.
  • Flexible study schedule with the option to complete a PG Diploma (coursework only) or PG Certificate.
  • Coordinated study programme with the PharmaTrain and the Faculty of Pharmaceutical Medicine of the Royal College of Physicians curricula.
  • The first UK course that complies with both the PharmaTrain initiative of the European Commission and the Bologna Process, and is the PharmaTrain Centre of Excellence.

Description

Clinical Pharmacology is the study of how drugs influence human physiology and the way the body responds. This study forms a vital part of the clinical development of new medicines and requires an advanced understanding of pre-clinical science, as well as the ethical and legal requirements for specialist research programmes. A well-designed clinical pharmacology programme informs the final regulatory of a new medicine. Therefore, generating skilled clinical pharmacologists is critical for the efficiency of future drug development.

This course will provide you with a broad knowledge and understanding of the drug development process and the medical aspects of the marketing of pharmaceutical products. You will also have opportunities to undertake advanced research projects and the possibility of one or more thesis publications.

The study programme is made up of optional and required modules. The MSc pathway requires modules totalling 180 credits to complete the programme, including 60 credits from a dissertation of around 15,000 - 18,000 words. The Postgraduate Diploma pathway will require modules totalling 120 credits, while the Postgraduate Certificate will require you to study modules totalling of 60 credits to complete the course.

If you are studying full-time, you will complete the course in one year, from September to September. If you are studying for the MSc qualification part-time, your programme will take up to four years to complete. The Postgraduate Diploma and Certificate pathways are both part-time courses. The Postgraduate Diploma will take two to three years to complete and the Postgraduate Certificate up to two years.

Course purpose

This course is for those working in or seeking to work in the field of clinical drug development. It covers all aspects of the clinical development process through from the earliest studies to post marketing activities. It will enhance knowledge and skills in all aspects of clinical research, drug regulation and drug safety.

Assessment

The primary method of assessment for this course is a combination of coursework and written examinations. The MSc study programme also requires a research and dissertation on the subject of clinical pharmacology.

The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they are subject to change.

Sign up for more information. Email now

Have a question about applying to King’s? Email now



Read less
OVERVIEW. The. Oncology Drug Discovery MSc. course is designed to provide an insight into how existing and future drug targets are identified from biological samples isolated from the cancer clinic. Read more

OVERVIEW

The Oncology Drug Discovery MSc course is designed to provide an insight into how existing and future drug targets are identified from biological samples isolated from the cancer clinic. This will include an industrial viewpoint into what makes an interesting target and how, through an iterative process, this target is validated. In addition, lectures will be provided to discuss how ‘hit’ compounds are identified, in both the academic and industrial setting, using compound screen assays and fragment based screening technologies. We will also provide an insight in computational methods for generating chemical ‘hits’. The module will also cover how these ‘hit’ compounds are prosecuted into tool compounds or Lead Optimisation candidates (LO), both historic and modern, that are used to further validate a potential drug target.

During this second module we will provide an insight into the challenges of moving a compound from an LO candidate to a pre-clinical candidate. How bio-marker companion tests are developed, validated and are used to underpin clinical trials. The lectures will also provide a keen insight into novel formulation strategies currently under development within Queen’s University Belfast. In addition, we will also provide an insight into the development of bio-therapeutics, such as antibodies, that are proving to be a powerful alternative to small molecule based therapeutics.

For further information email  or send us a message on WhatsApp

ONCOLOGY DRUG DISCOVERY HIGHLIGHTS

The strong links between us and the biotech and bio-pharmaceutical sectors provides a stimulating translational environment, while also expanding your career opportunities.

GLOBAL OPPORTUNITIES

INDUSTRY LINKS

  • Research projects will be provided by both academic staff and local biotech companies in ground-breaking research areas with a strong focus on clinical applications.

WORLD CLASS FACILITIES

  • The Oncology Drug Discovery course will be taught and mentored within the Centre for Cancer Research and Cell Biology: a purpose-built institute at the heart of the Health Sciences Campus, boasting state-of-the-art research facilities.

INTERNATIONALLY RENOWNED EXPERTS

  • We have an international reputation in this area, achieved through: high-impact peer review publications significant international research funding, the establishment of successful spin-out companies.

 

COURSE STRUCTURE

Research Project

  • You will undertake a lab based project in a number of different facets of the drug development, such as hit identification, hit compound development and therapeutic antibody development pathway working with both academic and biotech groups.Semester 1

Research Translational: from Concept to Commercialisation (Full Year)

  • This module covers the principles of disease biology and new technological developments that increase our understanding of disease processes. It develops an appreciation of the importance of innovation, business awareness and leadership skills in the translation of discovery science to clinical implementation.

Diagnosis and Treatment of Cancer

  • This module provides a comprehensive overview of the diagnosis and treatment of the common solid and haematological malignancies, including breast, ovarian, genitourinary and gastrointestinal cancers as well as the leukaemias

Cancer Biology

  • This module provides a comprehensive overview of the fundamental principles of carcinogenesis, highlighting how normal control processes are bypassed during tumour formation. The pathogenic mechanisms to be discussed will range from genomic alterations in key gene families, to epigenetic mechanisms of gene control, alterations in kinase activities or protein turnover, or activation of aberrant phenotypes such as invasion and angiogenesis.Semester 2

Target Identification and Development in Drug Discovery

  • This module describe how novel drug targets are identified and validated and identifies how biochemical assays are developed and employed in the drug discovery process. It also evaluates the alternative approaches used in the drug discovery to identify new chemical matter. It describes and defines chemical approaches used in developing ‘hit’ chemical compounds and identifies drug target classes and their drug-like pharmacophores.

Drug optimization, drug delivery and clinical trials

  • This module evaluates the issues associated the drug development process and describes the development, validation and use of bio-markers in the drug discovery process. It discusses the practices employed in clinical trials and defines the processes employed in licensing of new chemical equity and the role it plays in the drug discovery process.

For further information email  or send us a message on WhatsApp



Read less
The Drug Development Science course is a highly flexible study programme designed for those working in or seeking to work in the field of clinical drug development. Read more

The Drug Development Science course is a highly flexible study programme designed for those working in or seeking to work in the field of clinical drug development. The course aims to provide students with expertise and skills in all aspects of clinical research, drug regulation and drug safety.

Key benefits

  • King's is ranked 7th in the world for Pharmacy & Pharmacology (QS World University Rankings by Subject 2017)
  • The study programme is compliant with both the PharmaTrain initiative of the European Commission and also with the Bologna Process.
  • Close links and regular speakers from pharmaceutical companies giving you insights and up-to-the-minute knowledge of drug discoveries.
  • Highly flexible programme with a part-time option that will allow you to study around your work schedule.
  • Delivered by leading experts from the academic staff of King’s College London, the biopharmaceutical sector and the regulatory authorities.

Description

The Drug Development Science programme offers you flexibility with the choice of modules and whether to study for a full masters qualification, a Postgraduate Certificate or Diploma. The MSc pathway is a one to four-year course that requires modules totalling 180 credits. The Postgraduate Diploma pathway can be studied over a period of two to three years and requires completed modules with a total of 120 credits. The Postgraduate Certificate route requires modules with a minimum total of 60 credits to achieve the award.

Course format and assessment

Teaching

We use lectures, seminars and group tutorials to deliver most of the modules on the course. You will also be expected to undertake a significant amount of independent study. There are 30 hours of lectures, seminars and workshops per module. Each module requires 2 to 4 hours of pre-reading and also exam preparation. 

For the MSc there are approximately 80 hours of tutorials, plus supervision of dissertation research and ad hoc academic tutor meetings. Students could spend 200 to 300 hours researching and writing a dissertation. 

Typically, one credit equates to 10 hours of work

Assessment

You will be assessed through a combination of coursework, practical assessments and examinations.

The study time and assessment methods detailed above are typical and give you a good indication of what to expect.

Career prospects

 It is expected that students who complete this course will be able to work in the clinical research arena at a higher level and this will open up job opportunities that might have previously been beyond their reach and enhance their value to their employers.

Sign up for more information. Email now

Have a question about applying to King’s? Email now



Read less
Accelerated training for the Biopharmaceutical Industry. Application deadline. 17th June 2018. This unique professional training programme has been designed and developed in collaboration with the multinational Contract Research Organisation, . Read more

Accelerated training for the Biopharmaceutical Industry

Application deadline: 17th June 2018

This unique professional training programme has been designed and developed in collaboration with the multinational Contract Research Organisation, Covance.

The course is 20 months long, covering campus-based taught modules in the first six months, followed by a 12-month guaranteed paid placement in industry where you can expect to earn around £20,000.

During your training you’ll gain an integrated understanding of the full biological drug development pathway and the regulatory framework. The focus will be on large molecule drugs: monoclonal antibodies like Herceptin, bio-similars and antibody-drug conjugates; gene therapies and the technologies that underpin the discovery and development pathway.

You’ll be taught by leading industrialists and internationally renowned academics working at the forefront of their fields in the areas of science that support drug development. The curriculum is delivered primarily via project work in teams, and is assessed with outputs that are commonplace in industry, including presentations and reports to clients, regulators, investors/sponsors etc.

To prepare you for work in industry, you’ll also have access to cutting-edge practical technologies and gain hands-on practical training in protein purification, characterisation, formulation and assessment of binding function. In addition, you’ll use cell-based assays to look at drug potency, all performed in a strict regulated environment.

This course will help give you the experience and skills to become highly employable. Many pharmaceutical companies are expanding their biopharmaceutical capability, which is creating demand and opportunities for talented, well-trained people. At the same time, these companies report difficulties in recruiting employees with relevant skill sets and those with broad industrial experience are greatly sought after.

Course content

This course will provide you with an understanding of biological drug development focusing on each of the major steps of the process:

  • discovery
  • manufacturing
  • pre-clinical testing
  • clinical trials
  • market access and
  • the regulatory and legal aspects framework that ensure safe practice and the development of safe and effective medicines.

Course structure

The course is 20 months long, covering the campus-based taught elements in six to seven months, followed by a 12-month guaranteed paid work placement involving a research project where you’ll experience at first hand the working environment of this industry.

Work placement: an integral part of your training

An integral part of this course is your first paid job in industry. This is a 12-month guaranteed work and research experience in industry or placement hosted within the university research laboratories developed and co-supervised with industry. Students can expect to earn up to £20,000 over the duration of their placement.

The placements will all include a practical research project where you will gain in-depth practical experience of at least one technical function of the drug development process (discovery, manufacturing, pre-clinical testing, clinical safety and efficacy).

You will commence your project in May, six-months after the start of the programme and will be completed by the following April. Graduation is scheduled immediately thereafter, making you available for employment immediately after your placement.

These are typical modules/components studied and may change from time to time. Read more in our Terms and conditions.

Year 1

Over the first six to seven months starting in September you will study 100 credits worth of taught modules.

Compulsory modules:

  • Biopharmaceutical Development Pathway 5 credits
  • Biopharmaceutical Drug Discovery and Pre-Clinical Testing 20 credits
  • Manufacturing Biopharmaceuticals 20 credits
  • Integrated Drug Development Plan 10 credits
  • Biopharmaceutical Development: Clinical 10 credits
  • Commercialising Biopharmaceutical Products 10 credits
  • Practical Skills for a Regulatory Environment 25 credits

Year 2

Seven months after the start of the course (April/May), you will start a 12-month industrial placement where you will undertake a research project worth 80 credits.

Compulsory modules:

  • Industrial Placement & Research Project 80 credits

For more information on typical modules, read Biopharmaceutical Development MSc in the course catalogue

Learning and teaching

The learning and teaching on the course has been constructed to align with activities performed in industry, preparing you to be work-ready immediately after you finish.

You’ll have access to the very best learning resources and academic support during your studies. We’ve been awarded a Gold rating in the Teaching Excellence Framework (TEF, 2017), demonstrating our commitment to delivering consistently outstanding teaching, learning and outcomes for our students.

This course will challenge you to think creatively, solve problems and develop strong communication and teamwork skills. You’ll experience a wide range of teaching methods, including formal lectures, interactive workshops, practical classes and industry site visits.

You’ll extensively use of real-life, industry specific case studies to illustrate theoretical and practical concepts and multiple opportunities to work in teams, including the opportunity to lead a team. A wide range of ‘authentic’ assessments will be used that students will experience in the workplace including submissions to regulatory authorities, client reports and presentations to industry panel members.

Career opportunities

Your first steps into an industrial career

The course is designed to train talented scientists wishing to pursue a career in drug development in the international biopharmaceutical industry.

You’ll be exposed to senior industrialists working as tutors throughout the course and can take this opportunity to obtain career advice. You’ll also work in industry full time for 12 months, which is an outstanding opportunity for you to develop a competitive career plan.

With this degree, you’ll have the relevant knowledge and experience to fast-track your career as, for example, an analytical scientist, project manager, or coordinator, in areas such as research, quality control, manufacturing, project management, non-clinical, clinical, and market access.

As a student on this course you’ll have unique access to an industry-mentor and a personal tutor (academic member of staff) for the duration of your studies. You’ll also get support in planning your career through sessions that develop your CVs and applications.



Read less
This programme provides a broad overview of the drug discovery and development process and is designed for graduates in science-based subjects as preparation for either PhD-level research or a career in the pharmaceutical industry or with a government regulatory body. Read more

This programme provides a broad overview of the drug discovery and development process and is designed for graduates in science-based subjects as preparation for either PhD-level research or a career in the pharmaceutical industry or with a government regulatory body.

About this degree

You will gain hands-on experience of molecular modelling and computer-based drug design, and analytical and synthetic techniques and be exposed to modern platforms for drug discovery and methods of drug synthesis.

Students undertake modules to the value of 180 credits.

The programme consists of three core modules (90 credits), two optional modules (30 credits) and a dissertation (60 credits).

Core modules

  • Modern Aspects of Drug Discovery
  • The Process of Drug Discovery and Development I
  • The Process of Drug Discovery and Development II

Optional modules

Students choose two from the following:

  • Anticancer Personalised Medicines
  • New Drug Targets in the CNS
  • Pharmacogenics, Adverse Drug Reactions and Biomarkers
  • Advanced Structure-based Drug Design

Dissertation/report

All students undertake a laboratory-based research project which is assessed at the end of the year by a written report and oral presentation.

Teaching and learning

The programme is delivered through a combination of lectures, tutorials and seminars supported by the Blackboard e-learning system and practical classes. Assessment is through a combination of written examination and coursework. The research project is assessed by written report and oral presentation.

Further information on modules and degree structure is available on the department website: Drug Discovery and Development MSc

Careers

Students who complete the Drug Delivery and Development MSc will progress to careers in the various aspects of the pharmaceutical and biotechnology industries including research, product development and manufacturing, clinical trials and regulatory affairs.

Recent career destinations for this degree

  • PhD Medicinal Chemistry, UCL

Careers data is taken from the ‘Destinations of Leavers from Higher Education’ survey undertaken by HESA looking at the destinations of UK and EU students in the 2013–2015 graduating cohorts six months after graduation.

Why study this degree at UCL?

Lectures and seminars from industry-based scientists and visits to industrial and biotechnological research laboratories are key features of this programme.

Our graduates include international students from 24 different countries

The programme covers marketing, licensing and the regulatory affairs that form an integral part of the development process

Research Excellence Framework (REF)

The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.

The following REF score was awarded to the department: School of Pharmacy

87% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)

Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.



Read less

Show 10 15 30 per page



Cookie Policy    X